Latest News

  • FDA gives go ahead to Neurosteer brain monitoring platform

    The technology can aid in the early detection of Alzheimer's and Parkinson's disease

  • HomeCare Advocacy Network teams up with Zemplee to address ‘pressing’ caregiver shortage

    Former PayPal and Yahoo Executives leverage tech to help seniors age in place

  • New US$400,000 fund now available for Agetech innovators

    Innovators in the Agetech sector can now access up to US$400,000 from Centre for Ageing + Brain Health Innovation. The new fund will help grow and scale practical solutions for older adults and their caregivers. Eligible companies may also access additional investment of up to US$400,000 from the Ontario Brain Institute, commercialisation and funding support [...]

  • Five American companies that are building better senior care

    With one in six people in the world expected to be over 60 by 2030, building a better life for seniors has never been more important. Agetech World explores five American companies that are revolutionsing senior care. At the moment, the pace of population ageing is much faster than in the past. In 2020, the number [...]

  • Poor mental health accelerates ageing faster than smoking, study shows

    A new study suggests that a person’s mental health affects ageing just as much as physical health. Researchers from the Deep Longevity Limited in Hong Kong developed a deep learning ageing clock. An ageing clock is a statistical model that measures a person’s biological age instead of chronological age using blood, genetic and DNA data. [...]

  • At what point do dementia patients need 24-hour care?

    The decision to move a family member with dementia into a care home is not easy. Agetech World explores when it's the right time. Being a family member of someone with dementia, it may become difficult to decide at what point they need 24-hour care. A person with dementia will need more care and support [...]

  • New Alzheimer’s drug labelled “historic”

    A new drug appears to slow Alzheimer’s disease in what experts defined a “historic moment”. A new drug called lecanemab, has been developed by pharmaceutical companies Eisai and Biogen. The full details of the trial have not yet been published but it appears to slow the pace of brain’s decline. Scientists have injected 1,795 volunteers [...]

  • People with Glaucoma have higher risk of Alzheimer’s disease, study finds

    A new research suggests that people with normal-tension glaucoma are at increased risk of developing Alzheimer’s disease. The study, conducted in Taiwan, will be presented at the 126th annual meeting of the American Academy of Ophthalmology 2022. Researchers analysed data from the Taiwan National Health Insurance Research Database collected over a 12-year period. They compared [...]

  • New project to provide mental health care solution for older people

    The new mental health project is being tested to empower older people with mental health needs to regain their independence. The collaboration, between NHS Lancashire, South Cumbria Integrated Care Board, Lancashire County Council and Lancashire and South Cumbria NHS Foundation Trust, will assist mental health hospital patients who are ready for discharge. The older patients [...]

  • IU Alzheimer’s study awarded nearly US$50M to continue research

    IU Alzheimer’s research will receive US$48.8M over the next five years by the National Institute of Health (NIH). The second largest federally funded research programme at Indiana University School of Medicine will use the investments to fund the work of researchers as they seek to discover treatments for Alzheimer’s disease. In 2016, a branch of [...]